Myotonic Dystrophy 1; Dm1
Description
Myotonic dystrophy is an autosomal dominant disorder characterized mainly by myotonia, muscular dystrophy, cataracts, hypogonadism, frontal balding, and ECG changes. The genetic defect in DM1 results from an amplified trinucleotide repeat in the 3-prime untranslated region of a protein kinase gene. Disease severity varies with the number of repeats: normal individuals have 5 to 37 repeats, mildly affected persons have 50 to 150 repeats, patients with classic DM have 100 to 1,000 repeats, and those with congenital onset can have more than 2,000 repeats. The disorder shows genetic anticipation, with expansion of the repeat number dependent on the sex of the transmitting parent. Alleles of 40 to 80 repeats are usually expanded when transmitted by males, whereas only alleles longer than 80 repeats tend to expand in maternal transmissions. Repeat contraction events occur 4.2 to 6.4% of the time (Musova et al., 2009).
Clinical Features
Top most frequent phenotypes and symptoms related to Myotonic Dystrophy 1; Dm1
- Intellectual disability
- Seizures
- Generalized hypotonia
- Muscle weakness
- Muscular hypotonia
- Pain
- Cataract
- Ptosis
- Cognitive impairment
- Delayed speech and language development
And another 59 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— The onset for some of the known clinical features related to this disease may vary, including congenital onset .
Alternative names
Myotonic Dystrophy 1; Dm1 Is also known as dystrophia myotonica 1, dystrophia myotonica, steinert disease, dm.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Myotonic Dystrophy 1; Dm1 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
![]() By Baylor Miraca Genetics Laboratories (United States).
DMPK
Specificity
100 %
Genes
100 % |
![]() By Baylor Miraca Genetics Laboratories (United States).
DMPK
Specificity
100 %
Genes
100 % |
![]() By Athena Diagnostics Inc (United States).
DMPK
Specificity
100 %
Genes
100 % |
![]() By Athena Diagnostics Inc (United States).
SCN4A, CLCN1, DMPK
Specificity
34 %
Genes
100 % |
![]() By Athena Diagnostics Inc (United States).
SCN4A, CNBP, CAV3, CLCN1, DMPK, HSPG2, ATP2A1
Specificity
15 %
Genes
100 % |
![]() By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
DMPK
Specificity
100 %
Genes
100 % |
![]() By Molecular Pathology Laboratory University of Pennsylvania Health System (United States).
DMPK
Specificity
100 %
Genes
100 % |
![]() By CHEO Genetics Diagnostic Laboratory Children's Hospital of Eastern Ontario (Canada).
DMPK
Specificity
100 %
Genes
100 % |
You can get up to 47 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9 ROBERTS SYNDROME; RBS SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN CALCIFICATION OF JOINTS AND ARTERIES; CALJA